Changes of NK cells with natural cytotoxicity receptor (NCR) in preeclampsia

Placenta ◽  
2015 ◽  
Vol 36 (10) ◽  
pp. A13-A14
Author(s):  
Hideki Takahashi ◽  
Yusuke Kobayashi ◽  
Souichirou Kuno ◽  
Takayuki Matsuno ◽  
Takayuki Matsuno ◽  
...  
2020 ◽  
Vol 142 ◽  
pp. 103230
Author(s):  
Ayano Yamaya ◽  
Atsushi Fukui ◽  
Rie Fukuhara ◽  
Yoshihito Yokoyama ◽  
Hiroaki Shibahara

PLoS ONE ◽  
2018 ◽  
Vol 13 (2) ◽  
pp. e0193008 ◽  
Author(s):  
Kelly E. Bowen ◽  
Stephen O. Mathew ◽  
Kathleen Borgmann ◽  
Anuja Ghorpade ◽  
Porunelloor A. Mathew

2007 ◽  
Vol 37 (2) ◽  
pp. 445-455 ◽  
Author(s):  
Andrea De Maria ◽  
Manuela Fogli ◽  
Stefania Mazza ◽  
Monica Basso ◽  
Antonio Picciotto ◽  
...  

2019 ◽  
Vol 15 (4) ◽  
pp. e1007725 ◽  
Author(s):  
Katharina Pallmer ◽  
Isabel Barnstorf ◽  
Nicolas S. Baumann ◽  
Mariana Borsa ◽  
Stipan Jonjic ◽  
...  

2015 ◽  
Vol 112 ◽  
pp. 130-131
Author(s):  
Hideki Takahashi ◽  
Yusuke Kobayashi ◽  
Souichirou Kuno ◽  
Takayuki Matsuno ◽  
Takayuki Murase ◽  
...  

Viruses ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 156
Author(s):  
Jasmina M. Luczo ◽  
Sydney L. Ronzulli ◽  
Stephen M. Tompkins

Natural killer (NK) cells are part of the innate immunity repertoire, and function in the recognition and destruction of tumorigenic and pathogen-infected cells. Engagement of NK cell activating receptors can lead to functional activation of NK cells, resulting in lysis of target cells. NK cell activating receptors specific for non-major histocompatibility complex ligands are NKp46, NKp44, NKp30, NKG2D, and CD16 (also known as FcγRIII). The natural cytotoxicity receptors (NCRs), NKp46, NKp44, and NKp30, have been implicated in functional activation of NK cells following influenza virus infection via binding with influenza virus hemagglutinin (HA). In this review we describe NK cell and influenza A virus biology, and the interactions of influenza A virus HA and other pathogen lectins with NK cell natural cytotoxicity receptors (NCRs). We review concepts which intersect viral immunology, traditional virology and glycobiology to provide insights into the interactions between influenza virus HA and the NCRs. Furthermore, we provide expert opinion on future directions that would provide insights into currently unanswered questions.


2012 ◽  
Vol 35 (4) ◽  
pp. 594-600 ◽  
Author(s):  
Kenichiro Ito ◽  
Koji Higai ◽  
Chihiro Shinoda ◽  
Mizuha Sakurai ◽  
Kazuyuki Yanai ◽  
...  

Oncotarget ◽  
2017 ◽  
Vol 8 (38) ◽  
pp. 64344-64357 ◽  
Author(s):  
Kimberly Mayes ◽  
Zeinab Elsayed ◽  
Aiman Alhazmi ◽  
Michael Waters ◽  
Suehyb G. Alkhatib ◽  
...  

Blood ◽  
2002 ◽  
Vol 100 (6) ◽  
pp. 1935-1947 ◽  
Author(s):  
Sherif S. Farag ◽  
Todd A. Fehniger ◽  
Loredana Ruggeri ◽  
Andrea Velardi ◽  
Michael A. Caligiuri

AbstractNatural killer (NK) cells have held great promise for the immunotherapy of cancer for more than 3 decades. However, to date only modest clinical success has been achieved manipulating the NK cell compartment in patients with malignant disease. Progress in the field of NK cell receptors has revolutionized our concept of how NK cells selectively recognize and lyse tumor and virally infected cells while sparing normal cells. Major families of cell surface receptors that inhibit and activate NK cells to lyse target cells have been characterized, including killer cell immunoglobulinlike receptors (KIRs), C-type lectins, and natural cytotoxicity receptors (NCRs). Further, identification of NK receptor ligands and their expression on normal and transformed cells completes the information needed to begin development of rational clinical approaches to manipulating receptor/ligand interactions for clinical benefit. Indeed, clinical data suggest that mismatch of NK receptors and ligands during allogeneic bone marrow transplantation may be used to prevent leukemia relapse. Here, we review how NK cell receptors control natural cytotoxicity and novel approaches to manipulating NK receptor-ligand interactions for the potential benefit of patients with cancer.


Sign in / Sign up

Export Citation Format

Share Document